Designed for individuals with a BMI of 30 or higher, or 27 or higher with weight-related health issues, Wegovy is proven to help patients lose up to 15% of body weight over 68 weeks
The body mass index (BMI) is often used to diagnose obesity
By pairing a GLP-1 (which reduces overall mass) with Sermorelin (which signals the body to preserve muscle and burn fat), the theoretical outcome is a dramatic improvement in body compositiona greater percentage of fat loss relative to muscle loss
Timing exercise around the ODT dose requires minimal adjustment
Zepbound vial Additional options: Full membership access with Points, workshops, and coach support Bottom Line WeightWatchers Clinic isnt just a GLP-1 program but a multidisciplinary care team comprising board-certified clinicians, registered dietitians, and fitness coaches
Treating Metabolically Dysfunctional-Associated Steatohepatitis (MASH) A major update in 2026 is the use of semaglutide for weight loss patients who also suffer from MASH (formerly NASH)